Zoledronic acid increases bone mineral density in patients with thalassemia intermedia-induced osteoporosis despite the continuous bone marrow expansion

被引：0
|
作者：
Voskaridou, E.
Christoulas, D.
Antoniadou, L.
Tsaftaridis, P.
Plata, E.
Terpos, E.
机构：
[1] Laikon Gen Hosp, Thalassemia Ctr, Athens, Greece
[2] Gen Air Force Hosp 254, Athens, Greece
[3] Bioiatriki Med Ctr, Athens, Greece
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0914
引用
收藏
页码：342 / 342
页数：1
相关论文
共 50 条
  • [31] Bone mineral density in adult patients with major thalassemia
    Izadyar, Sina
    Fazeli, Mohammadali
    Izadyar, Mina
    Salamati, Peyman
    Gholamrezanezhad, Ali
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [32] High Circulating Levels of Sclerostin Correlate with Bone Mineral Density In Patients with Thalassemia and Osteoporosis: The Role of the Wnt Signaling In the Pathogenesis of Bone Loss In Thalassemia
    Voskaridou, Ersi
    Christoulas, Dimitrios
    Papatheodorou, Athanasios
    Bratengeier, Cornelia
    Plata, Eleni
    Kaliontzi, Despoina
    Woloszczuk, Wolfgang
    Terpos, Evangelos
    BLOOD, 2010, 116 (21) : 444 - 444
  • [33] Zoledronic Acid Markedly Improves Bone Mineral Density for Patients with Monoclonal Gammopathy of Undetermined Significance and Bone Loss
    Berenson, James R.
    Yellin, Ori
    Boccia, Ralph V.
    Flam, Marshall
    Wong, Siu-Fun
    Batuman, Olcay
    Moezi, Mehdi M.
    Woytowitz, Donald
    Duvivier, Herbert
    Nassir, Youram
    Swift, Regina A.
    CLINICAL CANCER RESEARCH, 2008, 14 (19) : 6289 - 6295
  • [34] The effect of zoledronic acid on bone mineral density and bone turnover in patients with early breast cancer on the AZURE trial
    Shankland, C.
    Coleman, R.
    BREAST, 2011, 20 : S71 - S71
  • [35] ASSOCIATION BETWEEN BONE METABOLISM MARKERS AND INCREASES IN BONE MINERAL DENSITY IN PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS TREATED WITH ROMOSOZUMAB
    Hattori, K.
    Kanayama, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1839 - 1840
  • [36] The effect of zoledronic acid on bone mineral density in patients undergoing androgen deprivation therapy
    Israeli, Ron S.
    Rosenberg, Steven J.
    Saltzstein, Daniel R.
    Gottesman, James E.
    Goldstein, Howard R.
    Hull, Gerald W.
    Tran, Diep N. H.
    Warsi, Ghulam M.
    Lacerna, Leo V.
    CLINICAL GENITOURINARY CANCER, 2007, 5 (04) : 271 - 277
  • [37] Lipid profile in β-thalassemia intermedia patients:: correlation with erythroid bone marrow activity
    Amendola, G.
    Danise, P.
    Todisco, N.
    D'Urzo, G.
    Di Palma, A.
    Di Concilio, R.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 (03) : 172 - 176
  • [38] Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis
    Uehara, Masashi
    Nakamura, Yukio
    Suzuki, Takako
    Nakano, Masaki
    Takahashi, Jun
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
  • [39] Frequency of Low Bone Mineral Density and Osteoporosis in Children with Beta Thalassemia Major
    Ishaq, Fouzia
    Anwar, Asma
    Iqbal, Mazher
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2015, 9 (03): : 1073 - 1076
  • [40] THE EVALUATION OF BONE MINERAL DENSITY AND OSTEOPOROSIS IN SCHIZOPHRENIC PATIENTS
    Ranjbar, F.
    Farjamfar, M.
    Aliasgarzadeh, A.
    Alizadeh, M.
    EUROPEAN PSYCHIATRY, 2010, 25
12345